SG10201407593RA - Separation method of nucleated cells derived from bone marrow for bone formation - Google Patents

Separation method of nucleated cells derived from bone marrow for bone formation

Info

Publication number
SG10201407593RA
SG10201407593RA SG10201407593RA SG10201407593RA SG10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA SG 10201407593R A SG10201407593R A SG 10201407593RA
Authority
SG
Singapore
Prior art keywords
bone
bone marrow
nucleated cells
bone formation
formation
Prior art date
Application number
SG10201407593RA
Inventor
Hyun-Shin Park
Jae-Deog Jang
Sae-Bom Lee
Cheong-Ho Chang
Original Assignee
Sewon Cellontech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sewon Cellontech Co Ltd filed Critical Sewon Cellontech Co Ltd
Publication of SG10201407593RA publication Critical patent/SG10201407593RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

9 SEPARATION METHOD OF NUCLEATED CELLS DERIVED FROM BONE MARROW FOR BONE The present invention relates to a method for separating bone marrow-derived nucleated cells for bone formation. The method comprises: the steps of: washing bone marrow; lysing red blood cells in the bone marrow; neutralizing the bone marrow lysate; purifying nucleated cells from the neutralized bone marrow; and mixing the nucleated cells with maintenance a buffer for bone formation. According to the invention, bone marrow-derived nucleated cells, which can be grafted into a site in need of bone formation or bone defect treatment, can be separated in a rapid and convenient manner. As a result, bone formation in emergency patients or patients, who require repeated surgical operations, can be effectively achieved by separating the nucleated cells for bone formation in surgical locations in a convenient and rapid manner and injecting the separated cells into the patients. No suitable figure
SG10201407593RA 2006-05-16 2006-06-23 Separation method of nucleated cells derived from bone marrow for bone formation SG10201407593RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060043936A KR100833793B1 (en) 2006-05-16 2006-05-16 Separation method of nucleated cells derived from bone marrow for bone formation

Publications (1)

Publication Number Publication Date
SG10201407593RA true SG10201407593RA (en) 2014-12-30

Family

ID=38694041

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201407593RA SG10201407593RA (en) 2006-05-16 2006-06-23 Separation method of nucleated cells derived from bone marrow for bone formation
SG2011035201A SG172595A1 (en) 2006-05-16 2006-06-23 Separation method of nucleated cells derived from bone marrow for bone formation

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011035201A SG172595A1 (en) 2006-05-16 2006-06-23 Separation method of nucleated cells derived from bone marrow for bone formation

Country Status (17)

Country Link
US (1) US20090111087A1 (en)
EP (1) EP2018419B1 (en)
JP (1) JP2009537215A (en)
KR (1) KR100833793B1 (en)
CN (1) CN101432421A (en)
BR (1) BRPI0621573A2 (en)
CY (1) CY1117747T1 (en)
DK (1) DK2018419T3 (en)
ES (1) ES2585231T3 (en)
HR (1) HRP20160966T1 (en)
HU (1) HUE029896T2 (en)
PL (1) PL2018419T3 (en)
PT (1) PT2018419T (en)
RS (1) RS54893B1 (en)
SG (2) SG10201407593RA (en)
SI (1) SI2018419T1 (en)
WO (1) WO2007132962A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104774805A (en) * 2015-04-03 2015-07-15 银广悦 Method for separating bone marrow mononuclear cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
US5824084A (en) * 1996-07-03 1998-10-20 The Cleveland Clinic Foundation Method of preparing a composite bone graft
JP4526749B2 (en) * 1999-05-28 2010-08-18 ステムセル テクノロジース インコーポレーテッド Cell separation method using immuno rosette
US7049093B2 (en) * 2000-11-08 2006-05-23 Sysmex Corporation Method of classifying and counting nucleated bone marrow cells
JP3929283B2 (en) * 2000-11-08 2007-06-13 シスメックス株式会社 Bone marrow nucleated cell classification and counting method
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
JP2005506525A (en) * 2001-07-27 2005-03-03 ベックマン コールター,インコーポレーテッド Methods for measuring nucleated red blood cells
WO2003040064A2 (en) * 2001-11-07 2003-05-15 Bioview Ltd. Kits and methods for preparing cell samples optimized for dual staining
KR20030085257A (en) * 2002-04-29 2003-11-05 주식회사 셀론텍 A blood bag and method for separating cell using of it
JP4087161B2 (en) * 2002-06-21 2008-05-21 シスメックス株式会社 Methods for detecting abnormalities in lymphocyte subsets
AU2003277610A1 (en) * 2002-11-08 2004-06-07 Shuichi Hanada Method of examining cancer cells and reagent therefor
JP2006055106A (en) * 2004-08-23 2006-03-02 National Institute Of Advanced Industrial & Technology Method for culturing mesenchymal stem cell derived from human bone marrow by using human serum culture medium

Also Published As

Publication number Publication date
EP2018419A1 (en) 2009-01-28
EP2018419B1 (en) 2016-05-04
DK2018419T3 (en) 2016-08-15
ES2585231T3 (en) 2016-10-04
CY1117747T1 (en) 2017-05-17
HUE029896T2 (en) 2017-04-28
PT2018419T (en) 2016-07-14
HRP20160966T1 (en) 2016-11-18
US20090111087A1 (en) 2009-04-30
EP2018419A4 (en) 2010-07-14
RS54893B1 (en) 2016-10-31
CN101432421A (en) 2009-05-13
JP2009537215A (en) 2009-10-29
KR20070111073A (en) 2007-11-21
KR100833793B1 (en) 2008-05-29
PL2018419T3 (en) 2016-11-30
SI2018419T1 (en) 2016-08-31
WO2007132962A1 (en) 2007-11-22
SG172595A1 (en) 2011-07-28
BRPI0621573A2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
WO2005038012A3 (en) Cartilage and bone repair and regeneration using postpartum-derived cells
WO2009059032A3 (en) Uses and isolation of very small embryonic-like (vsel) stem cells
MX2009005849A (en) Compositions and methods to treat cancer with cupredoxins and cpg rich dna.
WO2008051568A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2006135915A3 (en) Methods and compositions for treating degenerative bone disorders
WO2007127436A3 (en) Methods and compositions for repairing cartilage
WO2007117602A3 (en) Isolation and use of human regulatory t cells
WO2007092622A3 (en) Compositions and methods for treating bone
EA200900806A1 (en) METHODS OF INCREASING THE NUMBER AND MOBILIZATION OF HEMOPOETIC STEM CELLS
WO2009126786A3 (en) Improved quenching methods for red blood cell pathogen inactivation
WO2012006100A3 (en) Methods and compositions for enhancing stem cell mobilization
EP2126044A4 (en) Stem and progenitor cell compositions recovered from bone marrow or cord blood; system and method for preparation thereof
WO2007041546A3 (en) Method for selectively depleting hypoxic cells
WO2008127305A3 (en) Method of isolating biomacromolecules using low ph and divalent cations
WO2008058233A3 (en) In vivo bioreactors and methods of making and using same
WO2007054939A3 (en) Method for non-autologous cartilage regeneration
MX2010005863A (en) Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells.
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
WO2007082177A3 (en) Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity
WO2008066858A3 (en) Method of separating target dna from mixed dna
SG10201407593RA (en) Separation method of nucleated cells derived from bone marrow for bone formation
TW200510011A (en) A method for regeneration of bone
WO2003029432A3 (en) Human mesenchymal progenitor cell
MY160857A (en) A cancer vaccine
MX2009000643A (en) Method for collecting blood and transforming same into a hydrolyzed protein using slaughter animal blood, such as to obtain hydrolyzed blood protein.